Detection of ovarian cancer specific gene mutation in uterine secretion using LiquidSCA

Chung-Ang Univerisity Hospital0 个研究点目标入组 44 人开始时间: 待定最近更新: 2022年3月8日

试验速览

暂无简介。

•Normal group
•1. A woman between the ages of 20 and 70 who came to the hospital for routine examination
•2. A woman who has no abnormal findings in the endometrium or ovaries on ultrasound at the examination and normal PAP test within the last 2 years(if there is uterine fibroids or adenomyosis, it may be included in the this group)
•Benign ovarian cyst group
•1. Women between the ages of 20 and 70
•2. A woman who has no abnormal findings in the endometrium or ovaries on ultrasound, and normal PAP test within the last 2 years. (if there is uterine fibroids or adenomyosis, it may be included in this group)
•3. Imaging (US or MRI or CT), tumor marker level, or clinically not suspected ovarian cancer, fallopian tube cancer, or primary peritoneal cancer
•4. Patients whose ovaries or fallopian tubes are included in the surgical procedure.

•1. Patients who have previously had bilateral salpingectomy
•2. Patients who underwent tubal ligation for the purpose of contraception
•3. Patients who have received chemotherapy, radiotherapy, biological treatment, or drugs in clinical trials after being diagnosed with ovarian cancer
•4. Patients diagnosed with ovarian, fallopian, primary peritoneal cancer or metastasis of cancer to other organs in the final pathological examination.

发起方

Chung-Ang Univerisity Hospital